Literature DB >> 19298240

Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence.

S Zaidi1, O Elidemir, J S Heinle, E D McKenzie, M G Schecter, S L Kaplan, M K Dishop, D L Kearney, G B Mallory.   

Abstract

Mycobacterium abscessus is increasingly recognized as an important pathogen in some individuals with advancing lung disease related to cystic fibrosis (CF). Because of its resistance to antimicrobial agents and virulence, its presence in the lungs of potential lung transplant recipients can be problematic. We present 2 cases of individuals with CF in whom M. abscessus was present in the preoperative sputum cultures. The organism manifested different degrees of invasiveness in the 2 cases after transplantation with different outcomes, suggesting an approach to future candidates for lung transplantation that may be of clinical significance to their physicians and surgeons.

Entities:  

Mesh:

Year:  2009        PMID: 19298240     DOI: 10.1111/j.1399-3062.2009.00378.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  15 in total

1.  Multiple strains of non-tuberculous mycobacteria in a patient with cystic fibrosis.

Authors:  Sarah M N Brown
Journal:  J R Soc Med       Date:  2010-07       Impact factor: 5.344

Review 2.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

3.  Update on nontuberculous mycobacterial infections in solid organ and hematopoietic stem cell transplant recipients.

Authors:  B M Knoll
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

4.  Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients.

Authors:  Paul Saleeb; Kenneth N Olivier
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

5.  Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection.

Authors:  Don Hayes; Rajni Kant Shukla; Yizi Cheng; Emrah Gecili; Marlena R Merling; Rhonda D Szczesniak; Assem G Ziady; Jason C Woods; Luanne Hall-Stoodley; Namal Pm Liyanage; Richard T Robinson
Journal:  JCI Insight       Date:  2022-06-22

Review 6.  Non-tuberculous Mycobacterial Infections in Thoracic Transplant Candidates and Recipients.

Authors:  Mana Rao; Fernanda P Silveira
Journal:  Curr Infect Dis Rep       Date:  2018-05-12       Impact factor: 3.725

Review 7.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

8.  Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens.

Authors:  Kai Rüger; Annegret Hampel; Sandra Billig; Nadine Rücker; Sebastian Suerbaum; Franz-Christoph Bange
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

9.  Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections.

Authors:  Richard J Wallace; Gary Dukart; Barbara A Brown-Elliott; David E Griffith; Ernesto G Scerpella; Bonnie Marshall
Journal:  J Antimicrob Chemother       Date:  2014-03-14       Impact factor: 5.790

10.  Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management.

Authors:  Satish Chandrashekaran; Patricio Escalante; Cassie C Kennedy
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.